SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes
Condition: Type 2 Diabetes Interventions: Drug: Dapagliflozin; Drug: Metformin Sponsors: The George Institute; The University of New South Wales; Monash University; University of Sydney Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2022 Category: Research Source Type: clinical trials
Exposure Therapy Consortium (ETC) for Anxiety Sensitivity
Condition: Elevated Anxiety Sensitivity Interventions: Behavioral: Standard Exposure; Behavioral: Stress Management Training; Behavioral: Enhanced Exposure Sponsors: University of Texas at Austin; University of North Carolina, Chapel Hill; University of Colorado, Boulder; University of Miami; University of Mississippi, Oxford; Ruhr University of Bochum; Boston University; Fordham University; The University of New South Wales; Southern Methodist University; Institute of Behavioral-Therapy and -Medicine at the Philipps University Marburg; ...
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials
